Candel Therapeutics, Inc. CADL Net margin
Discontinued — last reported Q4 '22
Net margin at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Candel Therapeutics, Inc.’s 10-K, filed March 28, 2024, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s net margin?
- Candel Therapeutics, Inc. (CADL) reported net margin of -15,156.5% in Q4 2022.
- How has Candel Therapeutics, Inc.'s net margin changed year-over-year?
- Candel Therapeutics, Inc.'s net margin increased by 50.2% year-over-year, from -30,419.4% to -15,156.5%.
- What is the long-term trend for Candel Therapeutics, Inc.'s net margin?
- Over 2 years (2020 to 2022), Candel Therapeutics, Inc.'s net margin has grown at a 3.5% compound annual growth rate (CAGR), from -14,144% to -15,156.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.